Chlorambucil |
Leukeran |
Chlorambucil Systematic (IUPAC) name 4-[bis(2-chlorethyl)amino]benzenebutanoic acid Identifiers CAS number 305-03-3 ATC code ?? PubChem 2708 DrugBank APRD00115 Chemical data Formula C14H19Cl2NO2 Mol. weight ? Pharmacokinetic data Bioavailability ? Metabolism Hepatic Half life 1.5hrs Excretion N/A Therapeutic considerations Pregnancy cat. D(US) Legal status ℞ Prescription only Routes oral Chlorambucil (marketed as Leukeran by G ...
Wikipedia - [full article]
Chlorambucil Clinical Trials
- Randomized Trial of Chlorambucil Versus Chlorambucil Plus Rituximab in MALT Lymphoma
ClinicalTrials.gov Identifier: NCT00210353 - Recruiting
Lymphoma, Mucosa-Associated Lymphoid Tissue
- Chlorambucil Compared With No Further Therapy Following Anti- Helicobacter Therapy in Treating Patients With Low-Grade Lymphoma of the Stomach
ClinicalTrials.gov Identifier: NCT00003617 - Active, not recruiting
stage I gastric cancer
- Safety and Efficacy of SDX-101 (R-Etodolac) in Combination with Chlorambucil, and That of Chlorambucil Alone, in Patients with Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov Identifier: NCT00151736 - Active, not recruiting
Chronic Lymphocytic Leukemia
- Chlorambucil in Treating Patients With Advanced Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00017108 - Active, not recruiting
stage III chronic lymphocytic leukemia; stage IV chronic lymphocytic leukemia; B-cell Chronic Lymphocytic Leukemia
- Fludarabine or Chlorambucil as First-Line Therapy in Treating Older Patients With Previously Untreated Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00262795 - Active, not recruiting
Leukemia
- Chlorambucil Compared With Radiation Therapy in Treating Patients With Previously Untreated Stage III or Stage IV Follicular Lymphoma
ClinicalTrials.gov Identifier: NCT00028691 - Active, not recruiting
stage III grade 1 follicular lymphoma; stage III grade 2 follicular lymphoma; stage III grade 3 follicular lymphoma; ...
- Trial Comparing Chlorambucil to Fludarabine in Patients With Advanced Waldenström Macroglobulinemia
ClinicalTrials.gov Identifier: NCT00566332 - Recruiting
Waldenström Macroglobulinemia; Lymphoplasmacytic Lymphoma; Splenic Marginal Zone Lymphoma
- Dose Escalation Study of Gleevec and Chlorambucil in Previously Treated Chronic Lymphocytic Leukemia Patients
ClinicalTrials.gov Identifier: NCT00558961 - Recruiting
Chronic Lymphocytic Leukemia
- A Study of MabThera (Rituximab) Plus Chlorambucil in Patients With Chronic Lymphocytic Leukemia.
ClinicalTrials.gov Identifier: NCT00532129 - Recruiting
Lymphocytic Leukemia, Chronic
- Combination Chemotherapy in Treating Patients With Advanced Hodgkin's Disease
ClinicalTrials.gov Identifier: NCT00003421 - Active, not recruiting
stage II adult Hodgkin's disease; stage III adult Hodgkin's disease; stage IV adult Hodgkin's disease; stage I adult Hodgkin's disease
- Chemotherapy in Treating Patients With Newly Diagnosed Chronic Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00004218 - Active, not recruiting
stage I chronic lymphocytic leukemia; stage II chronic lymphocytic leukemia; stage III chronic lymphocytic leukemia; ...
- Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplantation in Treating Children With Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00025064 - Active, not recruiting
stage II childhood Hodgkin's lymphoma; stage I childhood Hodgkin's lymphoma; stage III childhood Hodgkin's lymphoma; ...
- Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00006250 - Active, not recruiting
stage III grade 1 follicular lymphoma; stage III grade 2 follicular lymphoma; stage III grade 3 follicular lymphoma; ...
- Combination Chemotherapy With or Without Interferon alfa in Treating Patients With Low-Grade Non-Hodgkin's Lymphoma
ClinicalTrials.gov Identifier: NCT00003639 - Active, not recruiting
stage III grade II follicular mixed cell lymphoma; stage IV grade II follicular mixed cell lymphoma; ...
- Efficacy/Safety of Frontline Alemtuzumab (Campath, MabCampath) vs Chlorambucil in Patients with Progressive B-Cell Lymphocytic Leukemia
ClinicalTrials.gov Identifier: NCT00046683 - Completed
B-cell Chronic Lymphocytic Leukemia
Resources
- Chlorambucil (Drug Digest)
- Leukeran (Drug Digest)

Not Signed In -

